Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy
Empower
1 other identifier
interventional
32
1 country
1
Brief Summary
The primary purpose of this study is to determine the feasibility of our proposed intervention approach involving (1) an integrated physiotherapy and exercise intervention for individuals with breast cancer who are undergoing chemotherapy and (2) delivery of programming via an electronic health (eHealth) application. The secondary objective is to determine the efficacy of the program on upper extremity outcomes, general physical fitness, cancer treatment-related symptoms and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Sep 2023
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2022
CompletedFirst Posted
Study publicly available on registry
February 24, 2022
CompletedStudy Start
First participant enrolled
September 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedFebruary 5, 2026
February 1, 2026
5 months
February 14, 2022
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion rate
Defined as \>70% participants completing at least 70% of exercise sessions and the post-study assessment
10 weeks
Secondary Outcomes (20)
Recruitment rate
one year
Attendance rate
10 weeks
Program Satisfaction
10 weeks
Symptoms
10 weeks
Health-related Quality of Life
10 weeks
- +15 more secondary outcomes
Other Outcomes (2)
Grip strength (optional)
10 weeks
Core muscular endurance (optional)
10 weeks
Study Arms (2)
Standard exercise program
ACTIVE COMPARATORParticipants in this group will take part the general exercise program delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application.
Integrated physiotherapy and exercise
EXPERIMENTALParticipants in this group will take part in an integrated physiotherapy and exercise intervention delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules.
Interventions
A 10-week integrated physiotherapy and general exercise intervention compared to a general exercise intervention alone.
Eligibility Criteria
You may qualify if:
- adult females with a diagnosis of breast cancer (Stage Ic-III);
- be able to participate in mild levels of activity at minimum;
- have completed cancer surgery involving a mastectomy or breast conserving surgery involving either an axillary lymph node dissection or sentinel lymph node biopsy;
- having completed or undergoing adjuvant chemotherapy +/- biological therapy treatment (eligible from 4 weeks to one year post-surgery at baseline);
- speak and understand English.
You may not qualify if:
- unable to commit to the 10-week virtual program including testing sessions at the Cancer Rehabilitation clinic in the Corbett Hall at the University of Alberta;
- do not have regular access to the internet and a smart device or computer in the home.
- are scheduled to undergo neoadjuvant chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alberta/ Cross Cancer Institute
Edmonton, Alberta, T6G 2G4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret McNeely
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Independent assessors will be used for collection of objective outcomes. The independent assessors will be blinded to group allocation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2022
First Posted
February 24, 2022
Study Start
September 20, 2023
Primary Completion
February 6, 2024
Study Completion
December 30, 2024
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- When study findings have been published
- Access Criteria
- The data on repository will be available on request to the principal investigator.
On completion of the trial, data will be available through the University of Alberta\'s Dataserve